Manidis Claims AI Scale Leaves Overlooked Outcomes for Big Firms

Will Manidis, a New York entrepreneur who founded ScienceIO, an AI biomedical company acquired in 2024, posted that the AI trade's totalizing scale means the biggest firms now overlook 10-20-30b outcomes in buckets once labeled too hard or too small. The post from his investor-tagged account states these sit waiting for notice. The packet contains only this single statement with no further updates or independent confirmations.